Lansoprazole Capsule, Delayed Release
Product Images NDC 63187-510

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 63187-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

63187-510-30 (Container2)

Lansoprazole 30 mg delayed release capsules label by Proficient Rx LP. The label states each capsule contains Lansoprazole USP 30 mg as enteric coated pellets in size '1' hard gelatin capsules. Capsules are characterized by a white to pale yellow pellet fill with opaque pink cap and black body, imprinted 'RDY' on the cap and '399' on the body. Label includes NDC 63187-510-30 and manufacturer Dr. Reddy's Laboratories Limited, India. Storage instructions and caution to keep out of reach of children are noted.*

FDA Label Image

Figure1 (Figure1)

A line graph depicting the mean severity of day heartburn by study day for evaluable patients. The y-axis represents mean severity of day heartburn on a scale from 0 to 2.5, and the x-axis shows days from the start of treatment, ranging from -5 to 60. The graph compares three groups: Placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, illustrating trends over time.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the mean severity of night heartburn over days from the start of treatment for evaluable patients. The severity scale ranges from 0 (none) to 3 (severe). Three groups are compared: Placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, with severity decreasing over time for each group.*

FDA Label Image

Structure (Structure)

Chemical structure of lansoprazole, showing its molecular arrangement with a benzimidazole ring, sulfoxide group, and substituted pyridine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.